Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Chronic Heart Failure

Free Subscription Articles published in PLoS One Retrieve available abstracts of 181 articles: HTML format

Single Articles

January 2025
1. KIM D, Park MS, Park JY, Song TJ, et al
   Association of varicose veins with the risk of heart failure: A nationwide cohort study.
   PLoS One. 2025;20:e0316942.
   PubMed     Abstract available
   
   
   
2. KRAUTER MB, McGilton KS, Patel SS, Harkness K, et al
   Home intravenous diuretic administration for heart failure management: A scoping review.
   PLoS One. 2025;20:e0316851.
   PubMed     Abstract available
   
   
   
3. PARK JS, Seo KW, Lee JE, Kim KH, et al
   Communication needs regarding heart failure trajectory and palliative care between patients and healthcare providers: A cross-sectional study.
   PLoS One. 2025;20:e0317417.
   PubMed     Abstract available
   
   
   
4. ZHANG Z, Wang C, Liu Q, Xiao Y, et al
   The risk of malnutrition as a predictor of arrhythmia recurrence after catheter ablation in patients with paroxysmal non-valvular atrial Fibrillation and heart failure with preserved ejection fraction.
   PLoS One. 2025;20:e0317721.
   PubMed     Abstract available
   
   
   
5. ZHANG J, Chen X, Lv S, Hao Q, et al
   Dapagliflozin inhibits ferroptosis to improve chronic heart failure by regulating Nrf2/HO-1/GPX4 signaling pathway.
   PLoS One. 2025;20:e0317295.
   PubMed     Abstract available
   
   
   
6. SOHN S, Jeon J, Lee JE, Park SH, et al
   Phase angle in bioelectrical impedance analysis for assessing congestion in acute heart failure.
   PLoS One. 2025;20:e0317333.
   PubMed     Abstract available
   
   
   
7. CHO Y, Shin SH, Park MA, Suh YJ, et al
   The effect of SGLT2 inhibitor in patients with type 2 diabetes and atrial fibrillation.
   PLoS One. 2025;20:e0314454.
   PubMed     Abstract available
   
   
   
8. FERGUSON C, William S, Allida S, Macdonald PS, et al
   A qualitative exploration of the educational needs of people living with heart failure: BANDAIDD-Explore study.
   PLoS One. 2025;20:e0314059.
   PubMed     Abstract available
   
   
   
9. TAKAHASHI R, Yokota J, Matsukawa Y, Matsushima K, et al
   Influence of inspiratory muscle strength on 6-minute walk distance in patients with acute heart failure.
   PLoS One. 2025;20:e0317679.
   PubMed     Abstract available
   
   
   
10. MASHITANI Y, Ogawa K, Funaki R, Tanaka Y, et al
    Association between mixed venous oxygen saturation and serum uric acid levels in patients with heart failure.
    PLoS One. 2025;20:e0306353.
    PubMed     Abstract available
    
    
    
11. SADAT-EBRAHIMI SR, Rezabakhsh A, Aslanabadi N, Asadi M, et al
    Correction: Novel diagnostic potential of miR-1 in patients with acute heart failure.
    PLoS One. 2025;20:e0320341.
    PubMed     Abstract available
    
    
    
12. HSU HR, Sekhar P, Grover J, Tian DH, et al
    Predictors of successful weaning from veno-arterial extracorporeal membrane oxygenation (V-A ECMO): A systematic review and meta-analysis.
    PLoS One. 2025;20:e0310289.
    PubMed     Abstract available
    
    
    
13. ALHARRASI M, Alnoumani H, Al-Ghassani A, Amirtharaj A, et al
    Family caregivers' contributions to self-care behaviors among heart failure patients in Oman.
    PLoS One. 2025;20:e0319827.
    PubMed     Abstract available
    
    
    
14. RUNG JM, Barrett TS, LeJeune K, Richards SB, et al
    Dosing patterns and dose effects of sacubitril/valsartan: A claims-based retrospective cohort study.
    PLoS One. 2025;20:e0320216.
    PubMed     Abstract available
    
    
    
15. ARUL JC, Raja Beem SS, Parthasarathy M, Kuppusamy MK, et al
    Association of microRNA-210-3p with NT-proBNP, sST2, and Galectin-3 in heart failure patients with preserved and reduced ejection fraction: A cross-sectional study.
    PLoS One. 2025;20:e0320365.
    PubMed     Abstract available
    
    
    
16. BLOMQVIST A, Stromberg A, Lundberg M, Back M, et al
    Exploring user experience: A qualitative analysis of the use of a physical activity support app for people with heart failure.
    PLoS One. 2025;20:e0309577.
    PubMed     Abstract available
    
    
    
17. VIJAYAKUMAR S, Corneau E, Erqou S, Kokkirala A, et al
    Outpatient care changes and associated mortality among Veterans with heart failure during the COVID-19 pandemic.
    PLoS One. 2025;20:e0323308.
    PubMed     Abstract available
    
    
    
18. NAKAMURA M, Yamamoto K, Nozaki S, Saeki T, et al
    Decline in oral function contributes to decreased activities of daily living at discharge in elderly patients with heart failure.
    PLoS One. 2025;20:e0323806.
    PubMed     Abstract available
    
    
    
19. WEIDENHAMMER A, Prausmuller S, Stadler M, Panagiotides N, et al
    Eligibility and GDMT up-titration success in heart failure: A real-world assessment.
    PLoS One. 2025;20:e0323952.
    PubMed     Abstract available
    
    
    
20. SU W, Wang X, Wang Q, Pei J, et al
    Association of predicted lean body mass and fat mass with prognosis in patients with heart failure preserved ejection fraction.
    PLoS One. 2025;20:e0323634.
    PubMed     Abstract available
    
    
    
21. YAZEW BG, Shitu WT, Salih MH, Aynalem ZB, et al
    Prevalence of the depression among heart failure patients in Ethiopia, 2024: A systematic review and meta-analysis.
    PLoS One. 2025;20:e0324530.
    PubMed     Abstract available
    
    
    
22. PEGRAM C, Diaz-Ordaz K, Brodbelt DC, Chang YM, et al
    Emulating the EPIC trial using VetCompass primary-care data: causal effects of pimobendan in UK dogs with grade IV/VI heart murmurs.
    PLoS One. 2025;20:e0325695.
    PubMed     Abstract available
    
    
    
23. LANG Y, Liang T, Li F
    Integrated multi-omics analysis and predictive modeling of heart failure using sepsis-related gene signature.
    PLoS One. 2025;20:e0326212.
    PubMed     Abstract available
    
    
    
24. OHNUKI Y, Suita K, Ishikawa M, Mototani Y, et al
    Epac1 increases myosin regulatory light-chain phosphorylation, energetic cost of contraction, and susceptibility to heart failure.
    PLoS One. 2025;20:e0325986.
    PubMed     Abstract available
    
    
    
25. LI AC, Lin YC, Huang JY, Chen LC, et al
    Superior cardiovascular protection with GLP-1 RAs over SGLT2 inhibitors in DM and HFpEF: A propensity score matching study.
    PLoS One. 2025;20:e0326534.
    PubMed     Abstract available
    
    
    
26. MACHADO-DUQUE ME, Gaviria-Mendoza A, Valladales-Restrepo LF, Sebastian Franco J, et al
    Heart failure treatment patterns: A pharmacoepidemiological descriptive study in Colombia (The HEATCO study).
    PLoS One. 2025;20:e0325515.
    PubMed     Abstract available
    
    
    
27. NING Z, Li B, Ning Z, Zhu B, et al
    Development and validation of a clinical prediction model for in-hospital heart failure risk following PCI in patients with coronary artery disease.
    PLoS One. 2025;20:e0325036.
    PubMed     Abstract available
    
    
    
28. BOO KY, Kim M, Lee JG, Ko G, et al
    Long-term benefit of vasodilating beta-blockers in acute myocardial infarction patients with mildly reduced left ventricular ejection fraction.
    PLoS One. 2025;20:e0326516.
    PubMed     Abstract available
    
    
    
29. EHRMAN RR, Haber BD, Harrison NE, Korzeniewski SJ, et al
    Increased social deprivation index scores are associated with 180-day readmissions, but not index admissions, for acute heart failure.
    PLoS One. 2025;20:e0327123.
    PubMed     Abstract available
    
    
    
30. BITOS K, Laptseva N, Haider T, Rossi VA, et al
    Effects of dapagliflozin on blood volume status and vascular outcomes in clinically stabilized heart failure patients after an acute decompensated heart failure event (DAPA-VOLVO study): Protocol of a double-blind randomized controlled clinical trial.
    PLoS One. 2025;20:e0325668.
    PubMed     Abstract available
    
    
    
31. BETANCOURT-PENA J, Portela-Pino I, Martinez-Patino MJ
    Study protocol for a controlled clinical trial on cardiac telerehabilitation and educational follow-up in patients with heart failure.
    PLoS One. 2025;20:e0327366.
    PubMed     Abstract available
    
    
    
32. MAZZUCCO G, Torres-Castro R, Intelangelo L, Lista-Paz A, et al
    Is non-invasive ventilation effective in improving the exercise capacity in patients with cardiac heart failure?: A randomised crossover trial.
    PLoS One. 2025;20:e0327399.
    PubMed     Abstract available
    
    
    
33. POHL A, Liljeroos M, Jaarsma T
    "The message hurts, but it would be worse if nothing was said" - Communicating severe illness and the imminence of death to patients with end stage heart failure and their families - A longitudinal interview study.
    PLoS One. 2025;20:e0328993.
    PubMed     Abstract available
    
    
    
34. SUN X, Sheng Y, Xu P, Peng Q, et al
    Vericiguat reduces atrial fibrillation recurrence by alleviating myocardial fibrosis via the TGF-beta1/Smad2/3 pathway.
    PLoS One. 2025;20:e0328272.
    PubMed     Abstract available
    
    
    
35. PARK J, Park CS, Rhee TM, Choi HJ, et al
    On-treatment blood pressure and dose-dependent effects of ARNI in heart failure with reduced ejection fraction: Insights from a multicenter registry.
    PLoS One. 2025;20:e0328971.
    PubMed     Abstract available
    
    
    
36. WANG Y, Xu W, Wang J, Shu Y, et al
    Relationship between stress hyperglycemia ratio of one-year mortality in patients with heart failure: Analysis of the MIMIC-IV database.
    PLoS One. 2025;20:e0328812.
    PubMed     Abstract available
    
    
    
37. MARCUS G, Monayer A, Moravsky G, Fuchs S, et al
    Limited predictive value of traditional comorbidities for readmission in acute decompensated heart failure.
    PLoS One. 2025;20:e0329829.
    PubMed     Abstract available
    
    
    
38. WILLIAMS TB, Parker P, Bimali M, Garza MY, et al
    Registered nurse effect on long length of stay in the heart failure hospitalizations of African Americans.
    PLoS One. 2025;20:e0329602.
    PubMed     Abstract available
    
    
    
39. LEDO APO, Matos SMA, Almeida MDCC, Aras R, et al
    Incidence and risk factors for heart failure in the ELSA-Brasil cohort.
    PLoS One. 2025;20:e0329113.
    PubMed     Abstract available
    
    
    
40. SUITA K, Hayakawa Y, Hoshino Y, Cai W, et al
    Water-soluble vidarabine derivatives alleviate catecholamine-induced heart failure and arrhythmia without impairing cardiac function in mice.
    PLoS One. 2025;20:e0330507.
    PubMed     Abstract available
    
    
    
41. SHEN X, Li W, Jiang X, Wen H, et al
    TGFBR1 gene silencing attenuates cardiomyopathy in the HFpEF mouse model.
    PLoS One. 2025;20:e0328981.
    PubMed     Abstract available
    
    
    
42. TATEISHI R, Miyazaki S, Yamao K, Negishi M, et al
    Evaluation of continuous arrhythmia monitoring using an implantable loop recorder in heart failure patients with a reduced ejection fraction: The LINQ2-HF trial rationale and protocol.
    PLoS One. 2025;20:e0321604.
    PubMed     Abstract available
    
    
    
43. KANAPARTHY NS, Possick S, Teng W, Maulion C, et al
    Impact of clinical pathways on enhancing compliance with evidence-based therapies for Heart failure with reduced ejection fraction-A retrospective cohort study.
    PLoS One. 2025;20:e0330188.
    PubMed     Abstract available
    
    
    
44. GAO Z, Liu X, Kang Y, Hu P, et al
    Explainable mortality prediction models incorporating social health determinants and physical frailty for heart failure patients.
    PLoS One. 2025;20:e0327979.
    PubMed     Abstract available
    
    
    
45. DU M, He S, Liu J, Yuan L, et al
    Uncovering key biomarkers, potential therapeutic targets and development of deep learning model in heart failure.
    PLoS One. 2025;20:e0330780.
    PubMed     Abstract available
    
    
    
46. TAHA K, Ross HJ, Peikari M, Mueller B, et al
    Predicting the future risk and outcomes of severe heart failure and coronary artery disease with machine learning in the UK Biobank Cohort.
    PLoS One. 2025;20:e0329461.
    PubMed     Abstract available
    
    
    
47. DAI L, Hu J, Yang Y, Qian B, et al
    1p-Enh-regulated CYP4B1 alleviates NNK-induced heart failure and lung cancer via the STAT3 pathway.
    PLoS One. 2025;20:e0331471.
    PubMed     Abstract available
    
    
    
48. NENDL A, Raju SC, Braadland PR, Nordborg A, et al
    Circulating metabolites in patients with chronic heart failure are not related to gut leakage or gut dysbiosis.
    PLoS One. 2025;20:e0331692.
    PubMed     Abstract available
    
    
    
49. AOKI T, Suzuki S, Minamisawa M, Yoshie K, et al
    A novel risk score model for predicting mortality in heart failure with preserved ejection fraction: Insights from the CURE-HF Registry-ApHAC score.
    PLoS One. 2025;20:e0332913.
    PubMed     Abstract available
    
    
    
50. YANG Y, Ou Y, Mo G, Wen J, et al
    Inhibition of LncRNA Kcnq1ot1 suppresses hypoxia-induced pyroptosis of H9C2 cells by regulating miR-27b-3p.
    PLoS One. 2025;20:e0332892.
    PubMed     Abstract available
    
    
    
51. LU M, Guo J, Yang P, Ma T, et al
    Insulin resistance markers HOMA-IR, TyG and TyG-BMI index in relation to heart failure risk: NHANES 2011-2016.
    PLoS One. 2025;20:e0331740.
    PubMed     Abstract available
    
    
    
52. LEHMANN A, Meslot C, Roustit M, Bardet JD, et al
    Development of a self-administered questionnaire to identify levers and barriers to adherence to medication regimens for chronic disease: The QUILAM project.
    PLoS One. 2025;20:e0323542.
    PubMed     Abstract available
    
    
    
53. WANG L, Wang Y
    Statin therapy and mortality in critically ill heart failure patients: Insights from a triangulated real-world design study.
    PLoS One. 2025;20:e0334822.
    PubMed     Abstract available
    
    
    
54. ABID L, Charfeddine S, Kammoun I, Halima MB, et al
    Correction: Epidemiology of heart failure and long-term follow-up outcomes in a north-African population: Results from the NAtional TUnisian REgistry of Heart Failure (NATURE-HF).
    PLoS One. 2025;20:e0335651.
    PubMed     Abstract available
    
    
    
55. BERGO KK, Norden ES, Bendiksen BA, Espe EKS, et al
    Sacubitril/valsartan preserves kidney function in rats with cardiorenal syndrome after myocardial infarction.
    PLoS One. 2025;20:e0335214.
    PubMed     Abstract available
    
    
    January 2024
56. EDWIN G, Alphonce B, Meremo A, Meda JR, et al
    Prevalence, clinical correlates and outcomes of cardiorenal anemia syndrome among patients with heart failure attending tertiary referral hospital in Dodoma, Tanzania: A protocol of a prospective observational study.
    PLoS One. 2024;19:e0292764.
    PubMed     Abstract available
    
    
    
57. SCHOLTEN M, Davidge J, Agvall B, Halling A, et al
    Comorbidities in heart failure patients that predict cardiovascular readmissions within 100 days-An observational study.
    PLoS One. 2024;19:e0296527.
    PubMed     Abstract available
    
    
    
58. AMMANAMANCHI N, Yester J, Bargaje AP, Thomas D, et al
    Elimination of 15N-thymidine after oral administration in human infants.
    PLoS One. 2024;19:e0295651.
    PubMed     Abstract available
    
    
    
59. SCHIAVO S, Brenna CTA, Albertini L, Djaiani G, et al
    Safety of hyperbaric oxygen therapy in patients with heart failure: A retrospective cohort study.
    PLoS One. 2024;19:e0293484.
    PubMed     Abstract available
    
    
    
60. INOUE N, Morikawa S, Ogane T, Hiramatsu T, et al
    Clinical value of the fibrosis-4 index in predicting mortality in patients with right ventricular pacing.
    PLoS One. 2024;19:e0294221.
    PubMed     Abstract available
    
    
    
61. JIANG L, Liu J, Yang Z, Wang J, et al
    Downregulation of the CD151 protects the cardiac function by the crosstalk between the endothelial cells and cardiomyocytes via exosomes.
    PLoS One. 2024;19:e0297121.
    PubMed     Abstract available
    
    
    
62. PALFFY E, Lewis DJ
    Real-World evidence revelations: The potential of patient support programmes to provide data on medication usage.
    PLoS One. 2024;19:e0295226.
    PubMed     Abstract available
    
    
    
63. MAEDA M, Humber D, Hida E, Ohtani T, et al
    Lower doses of carvedilol in Japanese heart failure patients with reduced ejection fraction could show the potential to be non-inferior to higher doses in US patients: An international collaborative observational study.
    PLoS One. 2024;19:e0299510.
    PubMed     Abstract available
    
    
    
64. CAGGIANELLI G, Alivernini F, Chirico A, Iovino P, et al
    The relationship between caregiver contribution to self-care and patient quality of life in heart failure: A longitudinal mediation analysis.
    PLoS One. 2024;19:e0300101.
    PubMed     Abstract available
    
    
    
65. NASCIMENTO PMC, Rodrigues Junior LF, Felix Mediano MF, Goncalves da Silva V, et al
    Prevalence and impact of sarcopenia in individuals with heart failure with reduced ejection fraction (the SARC-HF study): A prospective observational study protocol.
    PLoS One. 2024;19:e0300918.
    PubMed     Abstract available
    
    
    
66. CHENG T, Yu D, Qiu X, OuYang W, et al
    The relationship between a series of inflammatory markers on the risk of heart failure in different gender groups: Analysis from NHANES 2015-2018.
    PLoS One. 2024;19:e0296936.
    PubMed     Abstract available
    
    
    
67. MAURY P, Sanchis K, Djouadi K, Cariou E, et al
    Catheter ablation of atrial arrhythmias in cardiac amyloidosis: Impact on heart failure and mortality.
    PLoS One. 2024;19:e0301753.
    PubMed     Abstract available
    
    
    
68. WIEST C, Philipp A, Foltan M, Geismann F, et al
    Refractory circulatory failure in COVID-19 patients treated with veno-arterial ECMO a retrospective single-center experience.
    PLoS One. 2024;19:e0298342.
    PubMed     Abstract available
    
    
    
69. EL-MALAHI O, Mohajeri D, Mincu R, Bauerle A, et al
    Beneficial impacts of physical activity on heart rate variability: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0299793.
    PubMed     Abstract available
    
    
    
70. HUTTELMAIER MT, Munsterer S, Morbach C, Sahiti F, et al
    Activated rate-response is associated with increased mortality risk in cardiac device carriers with acute heart failure.
    PLoS One. 2024;19:e0302321.
    PubMed     Abstract available
    
    
    
71. SAIFAN AR, Hayeah HA, Ibrahim AM, Dimitri A, et al
    Experiences on health-related quality of life of Jordanian patients living with heart failure: A qualitative study.
    PLoS One. 2024;19:e0298893.
    PubMed     Abstract available
    
    
    
72. ZHANG X, Ho GWK, Mak YW
    Effectiveness of a videoconferencing group-based dyad acceptance and commitment therapy on the quality of life of chronic heart failure patients and their family caregivers: A study protocol for a randomized controlled trial.
    PLoS One. 2024;19:e0298178.
    PubMed     Abstract available
    
    
    
73. RYE CS, Ofstad AP, Asvold BO, Romundstad PR, et al
    The influence of diagnostic subgroups, patient- and hospital characteristics for the validity of cardiovascular diagnoses-Data from a Norwegian hospital trust.
    PLoS One. 2024;19:e0302181.
    PubMed     Abstract available
    
    
    
74. AL YOUNIS SM, Hadjileontiadis LJ, Khandoker AH, Stefanini C, et al
    Prediction of heart failure patients with distinct left ventricular ejection fraction levels using circadian ECG features and machine learning.
    PLoS One. 2024;19:e0302639.
    PubMed     Abstract available
    
    
    
75. LINDBERG F, Oigaard N, Metra M, Rosano GMC, et al
    Eligibility for omecamtiv mecarbil in a real-world heart failure population: Data from the Swedish Heart Failure Registry.
    PLoS One. 2024;19:e0303348.
    PubMed     Abstract available
    
    
    
76. ZACARIAS RONDINEL T, Bocchi L, Cipriano Junior G, Chiappa GRDS, et al
    Diaphragm thickness and mobility elicited by two different modalities of inspiratory muscle loading in heart failure participants: A randomized crossover study.
    PLoS One. 2024;19:e0302735.
    PubMed     Abstract available
    
    
    
77. NAMANJA A, Nyondo D, Banda T, Mndinda E, et al
    Delivering effective, comprehensive, multi-exercise component cardiac rehabilitation (CR) for chronic heart failure patients in low resource settings in sub-Saharan Africa: Queen Elizabeth Central Hospital-(QECH-CR) randomised CR study, Malawi.
    PLoS One. 2024;19:e0297564.
    PubMed     Abstract available
    
    
    
78. DURAN KAIRIES JV, Rice EJ, Stutz S, Tan SWY, et al
    Transform[ing] heart failure professionals with Indigenous land-based cultural safety in Ontario, Canada.
    PLoS One. 2024;19:e0302816.
    PubMed     Abstract available
    
    
    
79. XU P, Wei Y, Wu H, Zhang L, et al
    Genetic associations between Rapid Eye Movement (REM) sleep behavior disorder and cardiovascular diseases.
    PLoS One. 2024;19:e0301112.
    PubMed     Abstract available
    
    
    
80. SHEARER JJ, Hashemian M, Nelson RG, Looker HC, et al
    Demographic trends of cardiorenal and heart failure deaths in the United States, 2011-2020.
    PLoS One. 2024;19:e0302203.
    PubMed     Abstract available
    
    
    
81. LIU W, Lin Q, Fan Z, Cui J, et al
    Major depression disorder and heart failure: A two-sample bidirectional Mendelian randomization study.
    PLoS One. 2024;19:e0304379.
    PubMed     Abstract available
    
    
    
82. ZHOU Y, Zhao Q, Liu Z, Gao W, et al
    Blood urea nitrogen/creatinine ratio in heart failure: Systematic review and meta-analysis.
    PLoS One. 2024;19:e0303870.
    PubMed     Abstract available
    
    
    
83. MA TC, Gao F, Liu XL, Wang CX, et al
    Association between dietary inflammatory index and NT-proBNP levels in US adults: A cross-sectional analysis.
    PLoS One. 2024;19:e0304289.
    PubMed     Abstract available
    
    
    
84. DUBEY PK, Dubey S, Singh S, Bhat PD, et al
    Identification and development of Tetra-ARMS PCR-based screening test for a genetic variant of OLA1 (Tyr254Cys) in the human failing heart.
    PLoS One. 2024;19:e0293105.
    PubMed     Abstract available
    
    
    
85. KIM S, Perry LM, Mossman B, Dunn A, et al
    Financial burden and physical and emotional quality of life in COPD, heart failure, and kidney failure.
    PLoS One. 2024;19:e0306620.
    PubMed     Abstract available
    
    
    
86. SHIRIMA PM, Mkoka DA, Iseselo MK
    Nurses' perspectives on the provision of self-care management education to patients with heart failure: A qualitative study at Cardiac Hospital, Dar es Salaam Tanzania.
    PLoS One. 2024;19:e0306459.
    PubMed     Abstract available
    
    
    
87. DANG HNN, Viet Luong T, Cao MTT, Bui VT, et al
    Assessing red blood cell distribution width in Vietnamese heart failure patients: A cross-sectional study.
    PLoS One. 2024;19:e0301319.
    PubMed     Abstract available
    
    
    
88. KAMBALAPALLI S, Baral N, Paul TK, Upreti P, et al
    Thirty-day hospital readmission in females with acute heart failure and breast cancer: A retrospective cohort study from national readmission database.
    PLoS One. 2024;19:e0301596.
    PubMed     Abstract available
    
    
    
89. ZHOU J, Wu C, Zhao M
    TAOK1-mediated regulation of the YAP/TEAD pathway as a potential therapeutic target in heart failure.
    PLoS One. 2024;19:e0308619.
    PubMed     Abstract available
    
    
    
90. ZI-CHANG N, Xiao-Ling H, Qi J, Ting L, et al
    Ginseng Radix et Rhizoma enhanced the effect of metoprolol in chronic heart failure by inhibiting autophagy in male C57BL/6J mice.
    PLoS One. 2024;19:e0301875.
    PubMed     Abstract available
    
    
    
91. FUKUTA H, Goto T, Kamiya T
    Effects of calcium channel blockers in patients with heart failure with preserved ejection fraction: A protocol for systematic review and meta-analysis.
    PLoS One. 2024;19:e0307258.
    PubMed     Abstract available
    
    
    
92. HUANG CY, Overholser BR, Sowinski KM, Jaynes HA, et al
    Drug-induced QT interval prolongation in patients with heart failure with preserved ejection fraction.
    PLoS One. 2024;19:e0308999.
    PubMed     Abstract available
    
    
    
93. ALCOBERRO L, Moliner P, Vime J, Jimenez-Marrero S, et al
    Correction: Breaking the 30-day barrier: Long-term effectiveness of a nurse-led 7-step transitional intervention program in heart failure.
    PLoS One. 2024;19:e0309956.
    PubMed     Abstract available
    
    
    
94. TAN YJ, Linden S, Ong SC
    Cost-effectiveness of empagliflozin in the treatment of Malaysian patients with chronic heart failure and preserved or mildly reduced ejection fraction.
    PLoS One. 2024;19:e0305257.
    PubMed     Abstract available
    
    
    
95. SPADERNA H, Brandenburg VM, Lauterbach M, Partetzke TM, et al
    Associations of fear of physical activity, coping style and self-reported exercise behavior in patients with chronic heart failure.
    PLoS One. 2024;19:e0309952.
    PubMed     Abstract available
    
    
    
96. PEREZ MOLINA CJ, Castaneda Orjuela C, Valbuena Hernandez P, Perez Arias RI, et al
    Therapeutic interventions for heart failure in Colombia: result of a Delphi panel.
    PLoS One. 2024;19:e0304124.
    PubMed     Abstract available
    
    
    
97. SOLELA G
    Prevalence and prognostic role of hypochloremia in patients with acute heart failure in Ethiopia: A single-center retrospective analysis.
    PLoS One. 2024;19:e0310251.
    PubMed     Abstract available
    
    
    
98. KWAN ML, Pimentel N, Izano M, Iribarren C, et al
    Adherence to cardiovascular medications and risk of cardiovascular disease in breast cancer patients: A causal inference approach in the Pathways Heart Study.
    PLoS One. 2024;19:e0310531.
    PubMed     Abstract available
    
    
    
99. KIM J, Kim KH, Shin MS, Heo S, et al
    Evaluating dyadic factors associated with self-care in patients with heart failure and their family caregivers: Using an Actor-Partner Interdependence Model.
    PLoS One. 2024;19:e0308515.
    PubMed     Abstract available
    
    
    
100. MOMOT K, Krauz K, Czarzasta K, Tomaszewski J, et al
     Post-myocardial infarction heart failure and long-term high-fat diet: Cardiac endoplasmic reticulum stress and unfolded protein response in Sprague Dawley rat model.
     PLoS One. 2024;19:e0308833.
     PubMed     Abstract available
     
     
     
101. NGUYEN DV, Nguyen SV, Pham AL, Nguyen BT, et al
     Prognostic value of NT-proBNP in the new era of heart failure treatment.
     PLoS One. 2024;19:e0309948.
     PubMed     Abstract available
     
     
     
102. QIN X, Liu X, Guo C, Huang L, et al
     Medioresinol from Eucommiae cortex improves myocardial infarction-induced heart failure through activation of the PI3K/AKT/mTOR pathway: A network analysis and experimental study.
     PLoS One. 2024;19:e0311143.
     PubMed     Abstract available
     
     
     
103. TAMIR T, Nigussie J, Endawoke M
     Bridging the gap between recommendation and reality: Improving dietary adherence of heart failure populations a cross-sectional study in Ethiopia.
     PLoS One. 2024;19:e0311663.
     PubMed     Abstract available
     
     
     
104. MULUGETA H, Sinclair PM, Wilson A
     The experience of people living with heart failure in Ethiopia: A qualitative descriptive study.
     PLoS One. 2024;19:e0310600.
     PubMed     Abstract available
     
     
     
105. YONG VS, Raman S, Yen CH, Bahari MS, et al
     Evaluating the budget impact of Empagliflozin in managing heart failure with reduced ejection fraction: Proposing strategic policies for Malaysian public healthcare.
     PLoS One. 2024;19:e0313131.
     PubMed     Abstract available
     
     
     
106. CANTO ED, Uijl A, Onland-Moret NC, Bots SH, et al
     Simplification of a registry-based algorithm for ejection fraction prediction in heart failure patients: Applicability in cardiology centres of the Netherlands.
     PLoS One. 2024;19:e0310023.
     PubMed     Abstract available
     
     
     
107. THOMAZ SR, Goulart CDL, Turri-Silva N, Teixeira FA, et al
     Improving cardiorespiratory fitness and quality of life among heart failure patients: A comparative study of circuit resistance training and myofascial release techniques.
     PLoS One. 2024;19:e0299348.
     PubMed     Abstract available
     
     
     
108. HEARNS R, Ball SL, Wilkerson TL, Gee J, et al
     Training providers to implement heart failure shared medical appointments: A qualitative evaluation.
     PLoS One. 2024;19:e0310639.
     PubMed     Abstract available
     
     
     
109. HIBINO H, Gorniak SL
     Preliminary report: Reduced hand sensory and motor function in persons living with heart failure.
     PLoS One. 2024;19:e0312468.
     PubMed     Abstract available
     
     
     
110. GARCIA CA, Bardaji S, Perez-Tirador P, Otero A, et al
     RHRVEasy: Heart rate variability made easy.
     PLoS One. 2024;19:e0309055.
     PubMed     Abstract available
     
     
     
111. KIM M, Heo SJ, Kim MH, Park JW, et al
     Risk factors associated with SGLT2 inhibitor discontinuation in diabetic patients with heart failure.
     PLoS One. 2024;19:e0314305.
     PubMed     Abstract available
     
     
     
112. SAYGIN AVSAR T, Jackson L, Barton P, Beese S, et al
     Cost-effectiveness of Left Ventricular Assist Devices (LVADs) as destination therapy in the UK: An economic modelling study.
     PLoS One. 2024;19:e0312912.
     PubMed     Abstract available
     
     
     
113. TASHKOVSKA M, Krsteski S, Kizhevska E, Valic J, et al
     Predictive models for health-related quality of life built on two telemonitoring datasets.
     PLoS One. 2024;19:e0313815.
     PubMed     Abstract available
     
     
     
114. OCHIAI ME, Novaes KRV, Myakava LHK, Lima MV, et al
     Systemic vasoconstriction and mortality in patients with heart failure and reduced ejection fraction: A cohort of patients who underwent non-invasive hemodynamic monitoring.
     PLoS One. 2024;19:e0312582.
     PubMed     Abstract available
     
     
     
115. HAO Q, Lv S, Zhang J, Liu H, et al
     Effects of cardiac contractility modulation on autophagy and apoptosis of cardiac myocytes in rabbits with chronic heart failure.
     PLoS One. 2024;19:e0306242.
     PubMed     Abstract available
     
     
     
116. VAKHSHOORI M, Bondariyan N, Sabouhi S, Shakarami M, et al
     Impact of shock index (SI), modified SI, and age-derivative indices on acute heart failure prognosis; A systematic review and meta-analysis.
     PLoS One. 2024;19:e0314528.
     PubMed     Abstract available
     
     
     
117. DROZDOV I, Szubert B, Murphy C, Brooksbank K, et al
     Early detection of heart failure using in-patient longitudinal electronic health records.
     PLoS One. 2024;19:e0314145.
     PubMed     Abstract available
     
     
     
118. J ILONZE O, Knapp SM, Chernyak Y, Page RL 2nd, et al
     Cannabis use and heart transplant listing: A survey of clinician practices.
     PLoS One. 2024;19:e0310778.
     PubMed     Abstract available
     
     
     
119. HEYMAN ET, Ashfaq A, Ekelund U, Ohlsson M, et al
     A novel interpretable deep learning model for diagnosis in emergency department dyspnoea patients based on complete data from an entire health care system.
     PLoS One. 2024;19:e0311081.
     PubMed     Abstract available
     
     
     
120. BARNES-HARRIS MMM, Datla S, Abel A, Clark AL, et al
     Barriers and facilitators for cardiopulmonary resuscitation discussions with people with heart failure.
     PLoS One. 2024;19:e0314631.
     PubMed     Abstract available
     
     
     
121. KIM J, Kenyon J, Billingsley H, Bohmke N, et al
     Validity of the Actigraph-GT9X accelerometer for measuring steps and energy expenditures in heart failure patients.
     PLoS One. 2024;19:e0315575.
     PubMed     Abstract available
     
     
     January 2023
122. HU T, Yao W, Li Y, Liu Y, et al
     Interaction of acute heart failure and acute kidney injury on in-hospital mortality of critically ill patients with sepsis: A retrospective observational study.
     PLoS One. 2023;18:e0282842.
     PubMed     Abstract available
     
     
     
123. BORCHERS P, Pfisterer D, Scherpf M, Voigt K, et al
     Needs- and user-oriented development of contactless camera-based telemonitoring in heart disease-Results of an acceptance survey from the Home-based Healthcare Project (feasibility project).
     PLoS One. 2023;18:e0282527.
     PubMed     Abstract available
     
     
     
124. ANJULLO BB, Kumaso SK, Erango MA
     Joint modeling of longitudinal change in pulse rate and survival time of heart failure patients treated at Arbaminch General Hospital, Southern Ethiopia.
     PLoS One. 2023;18:e0282637.
     PubMed     Abstract available
     
     
     
125. CALLAHAN K, Acharya Y, Hollenbeak CS
     Validity of ICD codes to identify do-not-resuscitate orders among older adults with heart failure: A single center study.
     PLoS One. 2023;18:e0283045.
     PubMed     Abstract available
     
     
     
126. MULUGETA H, Sinclair PM, Wilson A
     Prevalence of depression and its association with health-related quality of life in people with heart failure in low- and middle-income countries: A systematic review and meta-analysis.
     PLoS One. 2023;18:e0283146.
     PubMed     Abstract available
     
     
     
127. BERGMARK RW, Jin G, Semco RS, Santolini M, et al
     Association of hospital centrality in inter-hospital patient-sharing networks with patient mortality and length of stay.
     PLoS One. 2023;18:e0281871.
     PubMed     Abstract available
     
     
     
128. MOON S, Liu S, Kshatriya BSA, Fu S, et al
     Assessing document section heterogeneity across multiple electronic health record systems for computational phenotyping: A case study of heart-failure phenotyping algorithm.
     PLoS One. 2023;18:e0283800.
     PubMed     Abstract available
     
     
     
129. EDMISTON JB, Cohn EG, Teruya SL, Sabogal N, et al
     Clinical and social determinants of health features of SARS-CoV-2 infection among Black and Caribbean Hispanic patients with heart failure: The SCAN-MP Study.
     PLoS One. 2023;18:e0283730.
     PubMed     Abstract available
     
     
     
130. KLEINMAN N, Kammerer J, LaGuerre K, Thakar CV, et al
     Social determinants of patiromer adherence and abandonment: An observational, retrospective, real-world claims analysis.
     PLoS One. 2023;18:e0281775.
     PubMed     Abstract available
     
     
     
131. HUMES HD, Aaronson KD, Buffington DA, Sabbah HN, et al
     Translation of immunomodulatory therapy to treat chronic heart failure: Preclinical studies to first in human.
     PLoS One. 2023;18:e0273138.
     PubMed     Abstract available
     
     
     
132. WU F, Nagele M, Cleres D, Haider T, et al
     Trends in voice characteristics in patients with heart failure (VENTURE) in Switzerland: Protocol for a longitudinal observational pilot study.
     PLoS One. 2023;18:e0283052.
     PubMed     Abstract available
     
     
     
133. LI Z, Liu M, Chen M, Luo G, et al
     Clinical effect of Danshen decoction in patients with heart failure: A systematic review and meta-analysis of randomized controlled trials.
     PLoS One. 2023;18:e0284877.
     PubMed     Abstract available
     
     
     
134. CATALANO S, Moyer J, Weaver A, Di Q, et al
     Associations between long-term fine particulate matter exposure and hospital procedures in heart failure patients.
     PLoS One. 2023;18:e0283759.
     PubMed     Abstract available
     
     
     
135. SIVAKUMAR B, Lemonde M, Stein M, Mak S, et al
     Patient perspectives on the use of mobile apps to support heart failure management: A qualitative descriptive study.
     PLoS One. 2023;18:e0285659.
     PubMed     Abstract available
     
     
     
136. GODA A, Yanagisawa Y, Takeuchi S, Takeuchi K, et al
     Characteristics of cardiopulmonary exercise testing in patients with combined post- and pre-capillary pulmonary hypertension due to left heart disease.
     PLoS One. 2023;18:e0286057.
     PubMed     Abstract available
     
     
     
137. JONES AK, Yan CL, Rivera Rodriquez BP, Kaur S, et al
     Role of wearable devices in cardiac telerehabilitation: A scoping review.
     PLoS One. 2023;18:e0285801.
     PubMed     Abstract available
     
     
     
138. KWAN JM, Arbune A, Henry ML, Hu R, et al
     Quantitative cardiovascular magnetic resonance findings and clinical risk factors predict cardiovascular outcomes in breast cancer patients.
     PLoS One. 2023;18:e0286364.
     PubMed     Abstract available
     
     
     
139. MALMBORG M, Assad Turky Al-Kahwa A, Kober L, Torp-Pedersen C, et al
     Specialized heart failure clinics versus primary care: Extended registry-based follow-up of the NorthStar trial.
     PLoS One. 2023;18:e0286307.
     PubMed     Abstract available
     
     
     
140. WILLIAMS TB, Crump A, Garza MY, Parker N, et al
     Care delivery team composition effect on hospitalization risk in African Americans with congestive heart failure.
     PLoS One. 2023;18:e0286363.
     PubMed     Abstract available
     
     
     
141. SEKO Y, Kato T, Morimoto T, Yaku H, et al
     Weight loss during follow-up in patients with acute heart failure: From the KCHF registry.
     PLoS One. 2023;18:e0287637.
     PubMed     Abstract available
     
     
     
142. AL SAIKHAN L, Park C, Tillin T, Jones S, et al
     Does 3D-speckle tracking echocardiography improve prediction of major cardiovascular events in a multi-ethnic general population? A Southall and Brent Revisited (SABRE) cohort study.
     PLoS One. 2023;18:e0287173.
     PubMed     Abstract available
     
     
     
143. ONG SC, Low JZ
     Financial burden of heart failure in Malaysia: A perspective from the public healthcare system.
     PLoS One. 2023;18:e0288035.
     PubMed     Abstract available
     
     
     
144. MCMAHON J, Brown Wilson C, Hill L, Tierney P, et al
     Optimising quality of life for people living with heart failure in care homes: Protocol for the co-design and feasibility testing of a digital intervention.
     PLoS One. 2023;18:e0288433.
     PubMed     Abstract available
     
     
     
145. INAGAKI N, Seto N, Lee K, Takahashi Y, et al
     The role of critical care nurses in shared decision-making for patients with severe heart failure: A qualitative study.
     PLoS One. 2023;18:e0288978.
     PubMed     Abstract available
     
     
     
146. HUANG AA, Huang SY
     Dendrogram of transparent feature importance machine learning statistics to classify associations for heart failure: A reanalysis of a retrospective cohort study of the Medical Information Mart for Intensive Care III (MIMIC-III) database.
     PLoS One. 2023;18:e0288819.
     PubMed     Abstract available
     
     
     
147. ZHANG X, Zhou K, You L, Zhang J, et al
     Risk prediction models for mortality and readmission in patients with acute heart failure: A protocol for systematic review, critical appraisal, and meta-analysis.
     PLoS One. 2023;18:e0283307.
     PubMed     Abstract available
     
     
     
148. GU S, Du X, Wang D, Yu Y, et al
     Effects of high intensity interval training versus moderate intensity continuous training on exercise capacity and quality of life in patients with heart failure: A systematic review and meta-analysis.
     PLoS One. 2023;18:e0290362.
     PubMed     Abstract available
     
     
     
149. BEKELE F, Tafese L, Demsash AW, Tesfaye H, et al
     Adherence to self-care practices and associated factors among heart failure patients in Ethiopia: A systematic review and meta-analysis.
     PLoS One. 2023;18:e0288824.
     PubMed     Abstract available
     
     
     
150. AL ATEAH G, Kirschfink A, Frick M, Almalla M, et al
     Echocardiographic determination of right ventricular volumes and ejection fraction: Validation of a truncated cone and rhomboid pyramid formula.
     PLoS One. 2023;18:e0290418.
     PubMed     Abstract available
     
     
     
151. BOROWIEC A, Ozdowska P, Rosinska M, Jagiello-Gruszfeld A, et al
     Prognostic value of coronary atherosclerosis and CAC score for the risk of chemotherapy-related cardiac dysfunction (CTRCD): The protocol of ANTEC study.
     PLoS One. 2023;18:e0288146.
     PubMed     Abstract available
     
     
     
152. DATTANI R, Ul-Haq Z, Shah M, Goldet G, et al
     Association and progression of multi-morbidity with Chronic Kidney Disease stage 3a secondary to Type 2 Diabetes Mellitus, grouped by albuminuria status in the multi-ethnic population of Northwest London: A real-world study.
     PLoS One. 2023;18:e0289838.
     PubMed     Abstract available
     
     
     
153. KUBILIUTE I, Vitkauskaite M, Urboniene J, Svetikas L, et al
     Clinical characteristics and predictors for in-hospital mortality in adult COVID-19 patients: A retrospective single center cohort study in Vilnius, Lithuania.
     PLoS One. 2023;18:e0290656.
     PubMed     Abstract available
     
     
     
154. MCHARO TL, Iseselo MK, Kahema SE, Tarimo EAM, et al
     Experiences of family caregivers in caring for patients with heart failure admitted at Jakaya Kikwete Cardiac Institute, Dar es Salaam, Tanzania: A qualitative study.
     PLoS One. 2023;18:e0280698.
     PubMed     Abstract available
     
     
     
155. CHEN CW, Chang CW, Lin YC, Chen WT, et al
     Comparison of clinical outcomes of angiotensin receptor blockers with angiotensin-converting enzyme inhibitors in patients with acute myocardial infarction.
     PLoS One. 2023;18:e0290251.
     PubMed     Abstract available
     
     
     
156. GARNIER A, Leroy J, Delomenie C, Mateo P, et al
     Modulation of cardiac cAMP signaling by AMPK and its adjustments in pressure overload-induced myocardial dysfunction in rat and mouse.
     PLoS One. 2023;18:e0292015.
     PubMed     Abstract available
     
     
     
157. S JARAB A, Al-Qerem WA, Hamam H, Abu Heshmeh S, et al
     Glycemic control and its associated factors among diabetic heart failure outpatients at two major hospitals in Jordan.
     PLoS One. 2023;18:e0285142.
     PubMed     Abstract available
     
     
     
158. SCHOLTEN M, Halling A
     Associations of heart failure to prevalence of haematologic- and solid malignancies in southern Sweden: A cross-sectional study.
     PLoS One. 2023;18:e0292853.
     PubMed     Abstract available
     
     
     
159. FERNANDEZ-MENDOZA G, Mendez-Fernandez A, Alves-Figueiredo HJ, Garcia-Rivas G, et al
     Exploring the mechanisms underlying stroke volume variability reduction in a murine model of heart failure with reduced ejection fraction.
     PLoS One. 2023;18:e0292687.
     PubMed     Abstract available
     
     
     
160. KIM JM, Maqsood MH, Makuvire T, McIlvennan CK, et al
     Gender-based differences in decision making, quality of life and survival among patients undergoing left ventricular assist device evaluation.
     PLoS One. 2023;18:e0293121.
     PubMed     Abstract available
     
     
     
161. WU KY, Wang X, Youngson E, Gouda P, et al
     Sex differences in post-operative outcomes following non-cardiac surgery.
     PLoS One. 2023;18:e0293638.
     PubMed     Abstract available
     
     
     
162. WHITTAKER H, Rothnie KJ, Quint JK
     Exploring the impact of varying definitions of exacerbations of chronic obstructive pulmonary disease in routinely collected electronic medical records.
     PLoS One. 2023;18:e0292876.
     PubMed     Abstract available
     
     
     
163. HUGHES-AUSTIN JM, Katz R, Majka DS, Criqui MH, et al
     Serum reactivity to citrullinated protein/peptide antigens and left ventricular structure and function in the Multi-Ethnic Study of Atherosclerosis (MESA).
     PLoS One. 2023;18:e0291967.
     PubMed     Abstract available
     
     
     
164. CANTERI AL, Gusmon LB, Boguszewski CL, Borba VZC, et al
     Bone quality, mineral density, and fractures in heart failure.
     PLoS One. 2023;18:e0293903.
     PubMed     Abstract available
     
     
     
165. KIYOMOTO K, Matsuo I, Suita K, Ohnuki Y, et al
     Oral angiotensin-converting enzyme inhibitor captopril protects the heart from Porphyromonas gingivalis LPS-induced cardiac dysfunction in mice.
     PLoS One. 2023;18:e0292624.
     PubMed     Abstract available
     
     
     
166. HWANG HJ, Lee TG
     Impact on clinical outcomes of renin-angiotensin system inhibitors against doxorubicin-related toxicity in patients with breast cancer and hypertension: A nationwide cohort study in South Korea.
     PLoS One. 2023;18:e0294649.
     PubMed     Abstract available
     
     
     
167. DURANTE A, Younas A, Cuoco A, Boyne J, et al
     Burden among informal caregivers of individuals with heart failure: A mixed methods study.
     PLoS One. 2023;18:e0292948.
     PubMed     Abstract available
     
     
     
168. BILIKUNDI P, Alphonce B, Nyundo A, Meda JR, et al
     Predictors and outcomes of cardiac dyssynchrony among patients with heart failure attending Benjamin Mkapa Hospital in Dodoma, central Tanzania: A protocol of prospective-longitudinal study.
     PLoS One. 2023;18:e0287813.
     PubMed     Abstract available
     
     
     
169. SURIT P, Wongtanasarasin W, Boonnag C, Wittayachamnankul B, et al
     Association between air quality index and effects on emergency department visits for acute respiratory and cardiovascular diseases.
     PLoS One. 2023;18:e0294107.
     PubMed     Abstract available
     
     
     
170. FUKUTA H, Goto T, Kamiya T
     Effects of beta-blocker withdrawal in patients with heart failure with preserved ejection fraction: A protocol for systematic review and meta-analysis.
     PLoS One. 2023;18:e0294347.
     PubMed     Abstract available
     
     
     
171. REYES-FARIAS CI, Reategui-Diaz M, Romani-Romani F, Prokop L, et al
     The effect of sodium-glucose cotransporter 2 inhibitors in patients with chronic kidney disease with or without type 2 diabetes mellitus on cardiovascular and renal outcomes: A systematic review and meta-analysis.
     PLoS One. 2023;18:e0295059.
     PubMed     Abstract available
     
     
     
172. KIM J, Jiang J, Shen S, Setoguchi S, et al
     Trends in cardiac rehabilitation rates among patients admitted for acute heart failure in Japan, 2009-2020.
     PLoS One. 2023;18:e0294844.
     PubMed     Abstract available
     
     
     
173. ZHANG Y, Aaronson KD, Gryak J, Wittrup E, et al
     Predicting need for heart failure advanced therapies using an interpretable tropical geometry-based fuzzy neural network.
     PLoS One. 2023;18:e0295016.
     PubMed     Abstract available
     
     
     
174. HUANG CH, Yang CT, Chang CC
     Traumatic brain injury and risk of heart failure and coronary heart disease: A nationwide population-based cohort study.
     PLoS One. 2023;18:e0295416.
     PubMed     Abstract available
     
     
     
175. SHI L, Huang L, Yin E, Deng J, et al
     Effect of pueraria on left ventricular remodelling in HFrEF: A systematic review and meta-analysis.
     PLoS One. 2023;18:e0295344.
     PubMed     Abstract available
     
     
     
176. AL YOUNIS SM, Hadjileontiadis LJ, Al Shehhi AM, Stefanini C, et al
     Investigating automated regression models for estimating left ventricular ejection fraction levels in heart failure patients using circadian ECG features.
     PLoS One. 2023;18:e0295653.
     PubMed     Abstract available
     
     
     
177. ZHANG J, Hu Z, Tan Y, Ye J, et al
     Causal relationship from heart failure to kidney function and CKD: A bidirectional two-sample mendelian randomization study.
     PLoS One. 2023;18:e0295532.
     PubMed     Abstract available
     
     
     
178. BEKELE F, Tafese L, Garbessa B, Tadasa S, et al
     Burden and predictors of heart failure treatment outcomes in Ethiopia: A systematic review and meta-analysis protocol.
     PLoS One. 2023;18:e0291686.
     PubMed     Abstract available
     
     
     
179. GIL KE, Mikrut K, Mazur J, Black AL, et al
     Risk stratification in patients with structurally normal hearts: Does fibrosis type matter?
     PLoS One. 2023;18:e0295519.
     PubMed     Abstract available
     
     
     January 2021
180. SU MI, Liu CW
     Neutrophil-to-lymphocyte ratio associated with an increased risk of mortality in patients with critical limb ischemia.
     PLoS One. 2021;16:e0252030.
     PubMed     Abstract available
     
     
     
181. WANG B, Chen J
     Establishment and validation of a predictive model for mortality within 30 days in patients with sepsis-induced blood pressure drop: A retrospective analysis.
     PLoS One. 2021;16:e0252009.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.